These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27144279)

  • 1. Efficacy and Safety of Tigecycline for Patients with Hospital-Acquired Pneumonia.
    Xu L; Wang YL; Du S; Chen L; Long LH; Wu Y
    Chemotherapy; 2016; 61(6):323-30. PubMed ID: 27144279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute liver failure caused by high-dose tigecycline: A case report.
    Zhang Y; Wang J; Tan Y; Wu J
    Int J Clin Pharmacol Ther; 2024 Jul; 62(7):339-344. PubMed ID: 38606856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobials.
    Powers JH
    Clin Infect Dis; 2012 Jun; 54(12):1710-3. PubMed ID: 22467671
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions with the absorption of tetracyclines.
    Neuvonen PJ
    Drugs; 1976; 11(1):45-54. PubMed ID: 946598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal ion-tetracycline interactions in biological fluids. 2. Potentiometric study of magnesium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline, and discussion of their possible influence on the bioavailability of these antibiotics in blood plasma.
    Berthon G; Brion M; Lambs L
    J Inorg Biochem; 1983 Aug; 19(1):1-18. PubMed ID: 6619838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tigecycline monotherapy versus combination therapy for the treatment of hospital-acquired pneumonia (HAP): a meta-analysis of cohort studies.
    Bai XR; Liu JM; Jiang DC; Yan SY
    J Chemother; 2018 May; 30(3):172-178. PubMed ID: 29405898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal ion-tetracycline interactions in biological fluids. Part 8. Potentiometric and spectroscopic studies on the formation of Ca(II) and Mg(II) complexes with 4-dedimethylamino-tetracycline and 6-desoxy-6-demethyl-tetracycline.
    Lambs L; Venturini M; Decock-Le Révérend B; Kozlowski H; Berthon G
    J Inorg Biochem; 1988 Jul; 33(3):193-210. PubMed ID: 3418341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical and biological dynamics of tetracyclines.
    Nelson ML
    Adv Dent Res; 1998 Nov; 12(2):5-11. PubMed ID: 9972116
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial Susceptibility among European Gram-Negative and Gram-Positive Isolates Collected as Part of the Tigecycline Evaluation and Surveillance Trial (2004-2014).
    Rodloff AC; Dowzicky MJ
    Chemotherapy; 2017; 62(1):1-11. PubMed ID: 27216271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
    Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis.
    Gong J; Su D; Shang J; Yu H; Du G; Lin Y; Sun Z; Liu G
    Medicine (Baltimore); 2019 Sep; 98(38):e17091. PubMed ID: 31567945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis.
    Wang J; Pan Y; Shen J; Xu Y
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):24. PubMed ID: 28381268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis.
    Zha L; Pan L; Guo J; French N; Villanueva EV; Tefsen B
    Adv Ther; 2020 Mar; 37(3):1049-1064. PubMed ID: 32006240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis.
    Mei H; Yang T; Wang J; Wang R; Cai Y
    J Antimicrob Chemother; 2019 Dec; 74(12):3423-3431. PubMed ID: 31377765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections: A Bayesian network meta-analysis of randomized clinical trials.
    Chen L; Liang X; Jiang J; Li X; Li Y
    Medicine (Baltimore); 2019 Oct; 98(40):e17436. PubMed ID: 31577763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study.
    Geng TT; Xu X; Huang M
    Medicine (Baltimore); 2018 Feb; 97(8):e9961. PubMed ID: 29465589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics of High-Dose Tigecycline in Patients with Sepsis or Septic Shock.
    Borsuk-De Moor A; Rypulak E; Potręć B; Piwowarczyk P; Borys M; Sysiak J; Onichimowski D; Raszewski G; Czuczwar M; Wiczling P
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections.
    Xie J; Roberts JA; Alobaid AS; Roger C; Wang Y; Yang Q; Sun J; Dong H; Wang X; Xing J; Lipman J; Dong Y
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once daily high dose tigecycline - pharmacokinetic/pharmacodynamic based dosing for optimal clinical effectiveness: dosing matters, revisited.
    Cunha BA; Baron J; Cunha CB
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):257-267. PubMed ID: 27917692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline-induced coagulopathy: a literature review.
    Cui N; Cai H; Li Z; Lu Y; Wang G; Lu A
    Int J Clin Pharm; 2019 Dec; 41(6):1408-1413. PubMed ID: 31713108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.